Vk2735 Drug
Obese Adults
Phase I
Recruiting
A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities
Sep 09, 2026
―
Vk2735
Weight Loss
Phase II
Completed
VK2735 for Weight Management Phase 2 (Venture Oral Dosing)
Feb 10, 2025
―
Vk2735
Weight Loss
Phase II
Completed
VK2735 for Weight Management Phase 2
Sep 28, 2023
―
Vk2735, Vk2735 Drug
Weight Loss, Nash
Phase I
Completed
Phase 1 Study to Evaluate the Safety and Tolerability of VK2735
Jan 10, 2022
―
Vk0214
Adrenomyeloneuropathy Form (Amn) Of X-Linked Adrenoleukodystrophy (X-Ald)
Phase I
Completed
A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN
Jun 28, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Viking Therapeutics (1VT) have in its pipeline
1VT is currently developing the following drugs: Vk2735 Drug, Vk2735, Vk2735. These drug candidates are in various stages of clinical development as the company works toward FDA approval.